Anxiety News and Research

Latest Anxiety News and Research

Jasmine can be used instead of sleeping pills or mood enhancers: Study

Instead of a sleeping pill or a mood enhancer, a nose full of jasmine from Gardenia jasminoides could also help: in collaboration with Dr. Olga Sergeeva and Prof. Helmut Hass from the Heinrich Heine University in Düsseldorf, researchers from Bochum led by Prof. Dr. Dr. Dr. Hanns Hatt have discovered that the two fragrances Vertacetal-coeur (VC) and the chemical variation (PI24513) have the same molecular mechanism of action and are as strong as the commonly prescribed barbiturates or propofol.

9 Jul 2010

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.

9 Jul 2010

Study: 30-minute massage improves psychological, physiological state of patients with tension headache

Researchers at the University of Granada -in collaboration with the Clinical Hospital San Cecilio and the University Rey Juan Carlos- have proven that the psychological and physiological state of patients with tension headache improves within 24 hours after receiving a 30-minute massage.

8 Jul 2010

20% of Canadians less sympathetic towards lung cancer sufferers

Canadian lung cancer patients are likely to suffer significant stigma due to the disease's link to smoking, a connection that may impact the care and treatment patients receive. According to a 16-country survey carried out by Ipsos MORI on behalf of The Global Lung Cancer Coalition, one in five Canadians admit feeling less sympathetic towards lung cancer sufferers because of its known association with smoking cigarettes and other tobacco products.

8 Jul 2010

Article related to MN-166 mechanism of action included in PNAS USA

MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today reported that the June 22, 2010 issue of Proceedings of the National Academy of Sciences USA included an article related to the mechanism of action of MN-166 (ibudilast), as an emerging therapeutic for neurological disorders.

8 Jul 2010

Scientist leads global discussion, research on insula

A scientist at Barrow Neurological Institute is leading the global discussion and research on a hidden lobe of the brain called the insula. A.D. "Bud" Craig, PhD, who began studying the often-ignored lobe more than two decades ago, has organized and edited a special edition of the journal Brain Structure and Function dedicated to the emerging medical and scientific interest in the insula.

8 Jul 2010

Pelosi urges Democrats to talk up health care; Businesses feel early impact of law

"Speaker Nancy Pelosi is doubling down on healthcare reform, betting that it will do Democrats more good than harm in November's elections," The Hill reports.

8 Jul 2010

First Edition: July 7, 2010

Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.

7 Jul 2010

Therapist competence strongly related to symptom improvement in some patients: Study

While studies have shown that cognitive therapy is an effective treatment for depression, it has still not been clear the role therapists' training and expertise plays in making treatment successful. A new study finds that depressed patients show more symptom improvement when their therapists more competently follow the guidelines for delivering cognitive therapy.

7 Jul 2010

Anxiety can cause individuals become more idealistic in religious belief, researchers find

Anxiety and uncertainty can cause us to become more idealistic and more radical in our religious beliefs, according to new findings by York University researchers, published in this month's issue of the Journal of Personality and Social Psychology.

7 Jul 2010

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.

7 Jul 2010

Shire receives FDA approval of Daytrana for ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).

7 Jul 2010

Debate over the ill effects of wind turbines on health

The National Health and Medical Research Council (NHMRC) studied the purported ill effects of the wind turbines on health before reporting that there was no evidence that the turbines' low frequency noise or shadow flicker made people ill.

6 Jul 2010

Study finds maltreatment during childhood associated with mental health disorders in young adulthood

Abuse and neglect during childhood appear to be associated with increased rates of mood, anxiety and substance use disorders among young adults, according to a report in the June issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Jul 2010

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Jul 2010

The heart and the psyche – Link between heart disease and anxiety-depressive disorders

According to a new report published in the acclaimed journal Archives of General Psychiatry, concomitant anxiety and other psychiatric illnesses in heart patients raise their risk of getting heart attacks, strokes, heart failure and early death.

5 Jul 2010

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Chelsea Therapeutics International, Ltd. announced the completion and favorable outcome of an independent Data Monitoring Committee (DMC) review of the safety and efficacy data from approximately half the target enrollment in Chelsea's Phase II trial of droxidopa in fibromyalgia.

2 Jul 2010

Does too much texting puts teenagers at risk?

A seemingly harmless method of communication - text messaging on mobile phones could damage teenagers physically and psychologically a new study has revealed.

1 Jul 2010

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Scientists are reporting a possible explanation for the symptoms of anxiety and depression that occur in some patients taking the popular statin family of anti-cholesterol drugs, and reported by some individuals on low-cholesterol diets. These symptoms could result from long-term, low levels of cholesterol in the brain, the report suggests. It appears in ACS' weekly journal Biochemistry.

1 Jul 2010

Calmspace fragrance product to fight claustrophobia

Claustrophobia can be a debilitating condition and while there are a variety of therapies and treatments that attempt to limit its effects, there has never been a truly convenient, discreet and portable option for those seeking immediate and impactful relief in the event of an ensuing claustrophobic attack. Now, Healthy Brands LLC is introducing calmspace™, which delivers a proprietary therapeutic formula of 100% natural fragrance extracts that may help manage the anxiety resulting from claustrophobic reactions.

30 Jun 2010

Anxiety News and Research

Latest Anxiety News and Research

Jasmine can be used instead of sleeping pills or mood enhancers: Study

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

Study: 30-minute massage improves psychological, physiological state of patients with tension headache

20% of Canadians less sympathetic towards lung cancer sufferers

Article related to MN-166 mechanism of action included in PNAS USA

Scientist leads global discussion, research on insula

Pelosi urges Democrats to talk up health care; Businesses feel early impact of law

First Edition: July 7, 2010

Therapist competence strongly related to symptom improvement in some patients: Study

Anxiety can cause individuals become more idealistic in religious belief, researchers find

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

Shire receives FDA approval of Daytrana for ADHD in adolescents

Debate over the ill effects of wind turbines on health

Study finds maltreatment during childhood associated with mental health disorders in young adulthood

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

The heart and the psyche – Link between heart disease and anxiety-depressive disorders

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Does too much texting puts teenagers at risk?

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Calmspace fragrance product to fight claustrophobia

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Anxiety News and Research

Latest Anxiety News and Research

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Newsletters you may be interested in